These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 20719223

  • 1. Cytology and cervical cancer surveillance in an era of human papillomavirus vaccination.
    Budd AC, Sturrock CJ.
    Sex Health; 2010 Sep; 7(3):328-34. PubMed ID: 20719223
    [Abstract] [Full Text] [Related]

  • 2. Monitoring the control of human papillomavirus (HPV) infection and related diseases in Australia: towards a national HPV surveillance strategy.
    Brotherton JM, Kaldor JM, Garland SM.
    Sex Health; 2010 Sep; 7(3):310-9. PubMed ID: 20719220
    [Abstract] [Full Text] [Related]

  • 3. Cancers attributable to human papillomavirus infection.
    Grulich AE, Jin F, Conway EL, Stein AN, Hocking J.
    Sex Health; 2010 Sep; 7(3):244-52. PubMed ID: 20719211
    [Abstract] [Full Text] [Related]

  • 4. Knowledge of human papillomavirus (HPV) and the HPV vaccine in a national sample of Australian men and women.
    Pitts MK, Heywood W, Ryall R, Smith AM, Shelley JM, Richters J, Simpson JM.
    Sex Health; 2010 Sep; 7(3):299-303. PubMed ID: 20719218
    [Abstract] [Full Text] [Related]

  • 5. Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era.
    Tota J, Mahmud SM, Ferenczy A, Coutlée F, Franco EL.
    Sex Health; 2010 Sep; 7(3):376-82. PubMed ID: 20719230
    [Abstract] [Full Text] [Related]

  • 6. Closing editorial: processes, opportunities and challenges after introduction of human papillomavirus vaccine.
    Brotherton JM, Fairley CK, Garland SM, Gertig D, Saville M.
    Sex Health; 2010 Sep; 7(3):397-8. PubMed ID: 21058499
    [No Abstract] [Full Text] [Related]

  • 7. What can surveillance of genital warts tell us?
    Fairley CK, Donovan B.
    Sex Health; 2010 Sep; 7(3):325-7. PubMed ID: 20719222
    [Abstract] [Full Text] [Related]

  • 8. Models of cervical screening in the era of human papillomavirus vaccination.
    Canfell K.
    Sex Health; 2010 Sep; 7(3):359-67. PubMed ID: 20719228
    [Abstract] [Full Text] [Related]

  • 9. National survey of general practitioners' experience of delivering the National Human Papillomavirus Vaccination Program.
    Brotherton JM, Leask J, Jackson C, McCaffery K, Trevena LJ.
    Sex Health; 2010 Sep; 7(3):291-8. PubMed ID: 20719217
    [Abstract] [Full Text] [Related]

  • 10. US physicians' intentions regarding impact of human papillomavirus vaccine on cervical cancer screening.
    Wong C, Berkowitz Z, Saraiya M, Wideroff L, Benard VB.
    Sex Health; 2010 Sep; 7(3):338-45. PubMed ID: 20719225
    [Abstract] [Full Text] [Related]

  • 11. Pap test update.
    Heley S.
    Aust Fam Physician; 2007 Mar; 36(3):112-5. PubMed ID: 17339970
    [Abstract] [Full Text] [Related]

  • 12. Population-level impact of the bivalent, quadrivalent, and nonavalent human papillomavirus vaccines: a model-based analysis.
    Van de Velde N, Boily MC, Drolet M, Franco EL, Mayrand MH, Kliewer EV, Coutlée F, Laprise JF, Malagón T, Brisson M.
    J Natl Cancer Inst; 2012 Nov 21; 104(22):1712-23. PubMed ID: 23104323
    [Abstract] [Full Text] [Related]

  • 13. For debate: that Australia should consider changing to the bivalent vaccine.
    Stern PL.
    Sex Health; 2010 Sep 21; 7(3):238-41. PubMed ID: 21058497
    [No Abstract] [Full Text] [Related]

  • 14. Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen-detected cervical precancer.
    Inturrisi F, Lissenberg-Witte BI, Veldhuijzen NJ, Bogaards JA, Ronco G, Meijer CJLM, Berkhof J.
    Int J Cancer; 2021 Jan 15; 148(2):320-328. PubMed ID: 32663316
    [Abstract] [Full Text] [Related]

  • 15. Human papillomavirus vaccines: an update for gynecologists.
    Ault KA.
    Clin Obstet Gynecol; 2008 Sep 15; 51(3):527-32. PubMed ID: 18677145
    [Abstract] [Full Text] [Related]

  • 16. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.
    Muñoz N, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, Garcia PJ, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Steben M, Bosch FX, Dillner J, Huh WK, Joura EA, Kurman RJ, Majewski S, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan JT, Lupinacci LC, Giacoletti KE, Sings HL, James MK, Hesley TM, Barr E, Haupt RM.
    J Natl Cancer Inst; 2010 Mar 03; 102(5):325-39. PubMed ID: 20139221
    [Abstract] [Full Text] [Related]

  • 17. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data.
    Donovan B, Franklin N, Guy R, Grulich AE, Regan DG, Ali H, Wand H, Fairley CK.
    Lancet Infect Dis; 2011 Jan 03; 11(1):39-44. PubMed ID: 21067976
    [Abstract] [Full Text] [Related]

  • 18. High prevalence of high-risk HPV genotypes other than 16 and 18 in cervical cancers of Curaçao: implications for choice of prophylactic HPV vaccine.
    Hooi DJ, Lissenberg-Witte BI, de Koning MNC, Pinedo HM, Kenter GG, Meijer CJ, Quint WG.
    Sex Transm Infect; 2018 Jun 03; 94(4):263-267. PubMed ID: 29021405
    [Abstract] [Full Text] [Related]

  • 19. [Preventing cancer: The role of Papillomavirus vaccination in the general population].
    Vié le Sage F, Cohen R.
    Bull Cancer; 2020 Jan 03; 107(1):10-20. PubMed ID: 31982092
    [Abstract] [Full Text] [Related]

  • 20. Human papilloma virus vaccines and their role in cancer prevention.
    Jones RW, Coughlan EP, Reid JS, Sykes P, Watson PD, Cook C.
    N Z Med J; 2007 Nov 30; 120(1266):U2829. PubMed ID: 18264198
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.